Brind.

Allogene Therapeutics, headquartered in South San Francisco, announced it will participate in an investor conference hosted by Citibank.

2 reports, 2 independent Updated Aug 27
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Allogene Therapeutics, headquartered in South San Francisco, announced it will participate in an investor conference hosted by Citibank.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Allogene Therapeutics is participating in Citi's investor conference from its HQ in South San Francisco.1 source
  2. The company is highlighted for its potential value and growth to investors.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireAllogene Therapeutics Announces Participation in Upcoming Investor Conference SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-sta
  • Simply Wall St.Allogene Therapeutics And 2 Other Promising Penny Stocks To Watch In the last week, the market has stayed flat, but it is up 11% over the past year with earnings expected to grow by 15% per annum in